Show simple item record

dc.contributor.authorHirst, Jenniferen
dc.contributor.authorEdgar, Jamesen
dc.contributor.authorEsteves, Typhaineen
dc.contributor.authorDarios, Frédéricen
dc.contributor.authorMadeo, Mariannaen
dc.contributor.authorChang, Jaeraken
dc.contributor.authorRoda, Ricardo Hen
dc.contributor.authorDürr, Alexandraen
dc.contributor.authorAnheim, Mathieuen
dc.contributor.authorGellera, Cinziaen
dc.contributor.authorLi, Junen
dc.contributor.authorZüchner, Stephanen
dc.contributor.authorMariotti, Caterinaen
dc.contributor.authorStevanin, Giovannien
dc.contributor.authorBlackstone, Craigen
dc.contributor.authorKruer, Michael Cen
dc.contributor.authorRobinson, Margareten
dc.date.accessioned2015-06-25T12:53:05Z
dc.date.available2015-06-25T12:53:05Z
dc.date.issued2015-06-17en
dc.identifier.citationHirst et al. Human Molecular Genetics (2015) Vol. 24 Issue 17, pp. 4984-4996. doi: 10.1093/hmg/ddv220en
dc.identifier.issn0964-6906
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/248711
dc.description.abstractAdaptor proteins (AP 1-5) are heterotetrameric complexes that facilitate specialized cargo sorting in vesicular-mediated trafficking. Mutations in AP5Z1, encoding a subunit of the AP-5 complex, have been reported to cause hereditary spastic paraplegia (HSP), although their impact at the cellular level has not been assessed.Here we characterize three independent fibroblast lines derived from skin biopsies of patients harbouring nonsense mutations in AP5Z1 and presenting with spastic paraplegia accompanied by neuropathy, parkinsonism or and/or cognitive impairment. In all three patient-derived lines we show that there is complete loss of AP-5 ζ protein and a reduction in the associated AP-5 µ5 protein. Using ultrastructural analysis we show that these patient-derived lines consistently exhibit abundant multilamellar structures that are positive for markers of endolysosomes and are filled with aberrant storage material organised as exaggerated multilamellar whorls, striated belts and 'fingerprint bodies'. This phenotype can be replicated in a HeLa cell culture model by siRNA knockdown of AP-5 ζ. The cellular phenotype bears striking resemblance to features described in a number of lysosomal storage diseases.Collectively, these findings reveal an emerging picture of the role of AP-5 in endosomal and lysosomal homeostasis, illuminates a potential pathomechanism which is relevant to the role of AP-5 in neurons, and expands the understanding of recessive HSPs. Moreover, the resulting accumulation of storage material in endolysosomes leads us to propose that AP-5 deficiency represents a new type of lysosomal storage disease.
dc.description.sponsorshipThis work was supported by the Wellcome Trust (086598; J.H., J.R.E. and M.S.R.), the European Union (OMICS Call, Neuromics project; F.D., A.D., T.E. and G.S.), Verum Foundation (G.S.), Programme d’Investissement d’Avenir (ANR-10-IAIHU-06; F.D., A. D., T.E. and G.S.), ERC starting grant (311149; F.D.), the Intramural Research Program of the NINDS, National Institutes of Health (J.C., R.H.R. and C.B.) and National Institutes of Health grant NS083739 (M.M. and M.C.K.), Doris Duke Foundation (Clinical Scientist Development Award to M.C.K.) and Healthcare Research of the Italian Ministry of Health (C.M. and C.G.). C.G. also received partial research support by AriSLA (NOVALS 2010). Funding to pay the Open Access publication charges for this article was provided by the Wellcome Trust.
dc.languageEnglishen
dc.language.isoenen
dc.publisherOxford University Press
dc.rightsAttribution 2.0 UK: England & Wales*
dc.rights.urihttp://creativecommons.org/licenses/by/2.0/uk/*
dc.titleLoss of AP-5 results in accumulation of aberrant endolysosomes: defining a new type of lysosomal storage diseaseen
dc.typeArticle
dc.description.versionThis is the final version. It was first published by OUP at http://dx.doi.org/10.1093/hmg/ddv220en
prism.endingPage4996
prism.publicationDate2015en
prism.publicationNameHuman Molecular Geneticsen
prism.startingPage4984
prism.volume24en
dc.rioxxterms.funderERC
dc.rioxxterms.funderNIH
dc.rioxxterms.funderWellcome Trust
dc.rioxxterms.projectid086598
dc.rioxxterms.projectid311149
dc.rioxxterms.projectidNS083739
dcterms.dateAccepted2015-06-09en
rioxxterms.versionofrecord10.1093/hmg/ddv220en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2015-06-17en
dc.contributor.orcidHirst, Jennifer [0000-0001-9063-8494]
dc.contributor.orcidEdgar, James [0000-0001-7903-8199]
dc.contributor.orcidRobinson, Margaret [0000-0003-0631-0053]
dc.identifier.eissn1460-2083
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idWellcome Trust (086598/Z/08/Z)
pubs.funder-project-idWellcome Trust (100140/Z/12/Z)


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 2.0 UK: England & Wales
Except where otherwise noted, this item's licence is described as Attribution 2.0 UK: England & Wales